Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise {Roots Analysis}

The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.

To order this 320+ page report, which features 45+ figures and 100+ tables, please visit this

The USD 6+ billion (by 2030) financial opportunity associated with nuclear medicine and radiopharmaceuticals manufacturing, has been analyzed across the following segments:

  • Target Disease Indication 
  • Breast Cancer
  • Chronic Lymphocytic Leukemia
  • Colorectal Cancer
  • Head and Neck Cancer
  • Lung Cancer
  • Lupus Nephritis
  • Melanoma
  • Multiple Myeloma
  • Primary Sjögren’s Syndrome
  • Others 
  • Target Immune Checkpoint
  • B7-H3
  • CD38
  • CD40
  • CD47
  • Others
  • Mechanism of Action
  • Inhibitory
  • Stimulatory
  • Therapeutic Modality
  • Monoclonal Antibody
  • Small Molecule
  • Type of Therapy 
  • Monotherapy 
  • Combination Therapy
  • Route of Administration
  • Intravenous
  • Subcutaneous
  • Others
  • Key Geographical Regions 
  • North America
  • Europe
  • Asia-Pacific and the Rest of the World 

The Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report features the following companies, which we identified to be key players in this domain:

  • Advanced Accelerator Applications
  • Belgian Nuclear Research Center (SCK•CEN)
  • Cardinal Health
  • China Isotope & Radiation Corporation
  • Curium Pharma
  • DuChemBio
  • Eckert & Ziegler
  • Eczacibasi-Monrol
  • GE Healthcare
  • Jubilant DraxImage
  • Lantheus Medical Imaging
  • Nihon Medi-Physics
  • Nordion
  • PETNET Solutions
  • SinoTau Pharmaceuticals

Table of Contents

1. Preface

2. Executive Summary

3. Introduction

4. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Industry Players): Current Market Landscape

5. Nuclear Medicine and Radiopharmaceuticals Manufacturers (Non-Industry Players): Current Market Landscape

6. Nuclear Medicine and Radiopharmaceuticals Manufacturers in North America

7. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Europe

8. Nuclear Medicine and Radiopharmaceuticals Manufacturers in Asia-Pacific And Rest of The World

9. Nuclear Medicine and Radiopharmaceuticals Manufacturers: Company Competitiveness Analysis

10. Partnerships and Collaborations

11. Production and Supply Chain of Medical Isotope Molybdenum-99 (Technetium-99m)

12. Market Forecast and Opportunity Analysis

13. Concluding Remarks

14. Executive Insights

15. Appendix 1: Tabulated Data

16. Appendix 2: List of Companies and Organizations

To purchase a copy, please visit

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415